Tests currently used to determine whether an unborn child has Down syndrome carry a small risk of miscarriage, but a new test for the genetic abnormality could solve that problem by getting results from a maternal blood sample. The test, expected on the market this year, analyzes fetal RNA and DNA in the maternal blood serum for specific genetic markers found on chromosome 21. The number of copies of each of these markers reveals whether the fetal DNA has an extra copy of the chromosome–the genetic variation that causes Down syndrome.
Cost: Not available
Other products in this section:
Learn today what the rest of the world won’t know until tomorrow, at Business of Blockchain 2019.Register now
We won’t use CRISPR to make super-smart babies—but only because we can’t
Gene experts speculate that our worst gene-editing fears won’t come true because they are too complex for us to pull them off.
Electric nanoparticles can target and kill cancer cells by zapping them
Particles that produce electrical signals when bombarded with ultrasound could be a way to direct a cell-killing treatment directly to tumors.
Gene engineers make super-size plants that are 40% larger
Researchers hope to create a new “green revolution” by improving photosynthesis.